Literature DB >> 15756450

High lymphatic vessel density correlates with overexpression of VEGF-C in gastric cancer.

Takashi Hachisuka1, Michihiro Narikiyo, Yukishige Yamada, Hirofumi Ishikawa, Masato Ueno, Hideki Uchida, Ryo Yoriki, Yuichirou Ohigashi, Katsuhiko Miki, Hidetoshi Tamaki, Takashi Mizuno, Yoshiyuki Nakajima.   

Abstract

Lymph node metastasis is one of the most important prognostic factors in malignant tumors. In this study, we investigated vascular endothelial growth factor (VEGF)-C expression in human gastric cancer using immunohistochemical techniques and determined the number of microvessels in peritumoral tissue. VEGF-C expression was positive in 22 of 79 cases (27.8%), and correlated with the presence of lymphatic invasion and lymph node metastasis. We confirmed by reverse transcription-polymerase chain reaction (RT-PCR) that VEGF-C mRNA expression is observed more commonly in cancer tissues than normal tissues. For 59 gastric tumors, we examined lymphatic vessel density (LVD) using the specific lymphatic vessel endothelial hyaluronan receptor (LYVE) -1 antibody. VEGF-C expression was observed in 10 of 25 cases (40%) that exhibited a high LVD. Furthermore, high LVD exhibited a significant correlation with VEGF-C expression. Our findings suggest that VEGF-C plays a pivotal role for lymphangiogenesis and tumor growth in gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15756450

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

1.  Curcumin suppresses lymphatic vessel density in an in vivo human gastric cancer model.

Authors:  Wei Da; Jinshui Zhu; Long Wang; Qun Sun
Journal:  Tumour Biol       Date:  2015-02-10

2.  Anti-PD-1 synergizes with cyclophosphamide to induce potent anti-tumor vaccine effects through novel mechanisms.

Authors:  Mikayel Mkrtichyan; Yana G Najjar; Estella C Raulfs; Maher Y Abdalla; Raed Samara; Rinat Rotem-Yehudar; Larry Cook; Samir N Khleif
Journal:  Eur J Immunol       Date:  2011-08-17       Impact factor: 5.532

3.  The clinicopathological significance of tissue levels of hypoxia-inducible factor-1alpha and vascular endothelial growth factor in gastric cancer.

Authors:  Seong-Eun Kim; Ki-Nam Shim; Sung-Ae Jung; Kwon Yoo; Joo Ho Lee
Journal:  Gut Liver       Date:  2009-06-30       Impact factor: 4.519

4.  Different significance between intratumoral and peritumoral lymphatic vessel density in gastric cancer: a retrospective study of 123 cases.

Authors:  Xiao-Lei Wang; Jian-Ping Fang; Ru-Yong Tang; Xi-Mei Chen
Journal:  BMC Cancer       Date:  2010-06-17       Impact factor: 4.430

5.  Histopathological predictor for regional lymph node metastasis in gastric cancer.

Authors:  Hiroshi Morita; Yukio Ishikawa; Yuri Akishima-Fukasawa; Kinji Ito; Yoshikiyo Akasaka; Chiaki Nishimura; Yoshinori Igarashi; Kazumasa Miki; Toshiharu Ishii
Journal:  Virchows Arch       Date:  2008-12-23       Impact factor: 4.064

Review 6.  Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?

Authors:  Theodore D Tsirlis; George Papastratis; Kyriaki Masselou; Christos Tsigris; Antonis Papachristodoulou; Alkiviadis Kostakis; Nikolaos I Nikiteas
Journal:  World J Gastroenterol       Date:  2008-05-07       Impact factor: 5.742

7.  Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth.

Authors:  Xiaolei Wang; Ximei Chen; Jianping Fang; Changqing Yang
Journal:  Int J Clin Exp Pathol       Date:  2013-03-15

8.  First international consensus on the methodology of lymphangiogenesis quantification in solid human tumours.

Authors:  I Van der Auwera; Y Cao; J C Tille; M S Pepper; D G Jackson; S B Fox; A L Harris; L Y Dirix; P B Vermeulen
Journal:  Br J Cancer       Date:  2006-11-21       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.